Company Information
USD
1.985
- (-4.1%)
NASDAQ:MRVI, MARAVAI LIFESCIENCES HOLDINGS, INC.
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Address
10770 Wateridge Circle
Suite 200
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Carl W. Hull
Chairman of the Board/Co-Founder/Director
Mr. Gregory T. Lucier
Director
Dr. John A. DeFord, PhD
Director
Dr. Jessica Hopfield, PhD
Director
Mr. Kevin Herde
CFO/Chief Accounting Officer
Mr. Sean L. Cunningham
Director
Mr. Constantine S. Mihas
Director
Ms. Anat Ashkenazi
Director
Mr. Benjamin Daverman
Director
Ms. Susannah Gray, M.B.A.
Director
Mr. Luke Marker
Director
Dr. Murali K. Prahalad
Director
Mr. William Martin, III
CEO
Mr. Andrew Burch
Executive VP/General Manager, Divisional
Dr. Peter M. Leddy, PhD
Chief Administrative Officer
Ms. Christine Dolan
COO, Divisional
Mr. Kurt Oreshack
General Counsel/Secretary
Ownership
Institution Holdings
GTCR LLC
21,681,033 (16.402%)
12 West Capital Management LP
11,602,988 (8.778%)
Vanguard Group Inc
10,003,894 (7.568%)
BlackRock Inc
6,481,668 (4.903%)
Massachusetts Financial Services Company
6,014,575 (4.550%)
MFS Investment Management KK
6,014,575 (4.550%)
Millennium Management LLC
5,786,849 (4.378%)
Mackenzie Investments
5,169,176 (3.910%)
BRAIDWELL LP
3,974,857 (3.007%)
Glenmede Investment Management, LP
3,818,820 (2.889%)
Individual Holdings
Mr. William Martin, III
1,040,273 (0.787%)
Mr. Andrew Burch
436,793 (0.330%)
Dr. Peter M. Leddy, PhD
383,073 (0.290%)
Ms. Rebecca Buzzeo
369,432 (0.280%)
Mr. Kevin Herde
341,538 (0.258%)
Mr. Carl W. Hull
284,632 (0.215%)
Ms. Christine Dolan
263,390 (0.199%)
Mr. Kurt Oreshack
227,900 (0.172%)
Dr. Jessica Hopfield, PhD
90,123 (0.068%)
Ms. Susannah Gray, M.B.A.
60,123 (0.046%)
Funds Holdings
Pacer US Cash Cows 100 ETF
3,160,665 (2.391%)
Vanguard Small Cap Index
2,700,527 (2.043%)
Columbia Acorn Fund
2,274,568 (1.721%)
MFS Mid Cap Value Equity
1,663,874 (1.259%)
Vanguard Institutional Extnd Mkt Idx Tr
1,641,732 (1.242%)
Vanguard Small Cap Growth Index Fund
1,504,447 (1.138%)
MFS New Discovery Value Fund
1,180,064 (0.893%)
MFS Core Equity Fund
996,486 (0.754%)
iShares Biotechnology ETF
843,753 (0.638%)
State Street Russell Small/Mid Cap®
668,309 (0.506%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
